UCSF

ZINC19702112

Substance Information

In ZINC since Heavy atoms Benign functionality
November 6th, 2008 14 No

Other Names:

(4-amino-1-hydroxy-1-phosphono-butyl)phosphonic acid; Arendal; alendronate

(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid

(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)

(4-Amino-1-hydroxybutane-1,1-diyl)diphosphonic acid

(4-Amino-1-hydroxybutane-1,1-diyl)diphosphonic acid, sodium salt

(4-Amino-1-hydroxybutane-1,1-diyl)diphosphonicacid

(4-Amino-1-hydroxybutylidene)bisphosphonic acid

(4-Amino-1-hydroxybutylidene)bisphosphonic acid; 66376-36-1; Alendronate; Alendronic acid; C07752

(4-Amino-1-hydroxybutylidene)diphosphonic acid

121268-17-5 (mono-hydrochloride salt, trihydrate)

121268-17-5; Alendronate sodium (USAN); Alendronate sodium hydrate (JP16); Binosto (TN); D00939; Fosamax (TN)

1yhm

4-Aamino-1-hydroxy-1-phosphonobutyl phosphonic acid monosodium

4-AMINO-1-HYDROXY-1-PHOSPHONOBUTYL PHOSPHONIC ACID,MONOSODIUM

4-amino-1-hydroxy-1-phosphonobutylphosphonic acid

4-Amino-1-hydroxybutane-1,1-diphosphonate

4-Amino-1-hydroxybutane-1,1-diphosphonic Acid

4-Amino-1-hydroxybutane-1,1-diyldiphosphonic acid

4-Amino-1-hydroxybutylidene-1,1-bis(phosphonic acid)

4-Amino-1-hydroxybutylidene-1,1-bisphosphonate

66376-36-1

66376-36-1; Alendronic acid (INN); D07119

AC1L1CW3

Acide alendronique

Acide Alendronique [INN-French]

Acido alendronico

Acido Alendronico [INN-Spanish]

Acidum alendronicum

Acidum Alendronicum [INN-Latin]

Adronat

Adronat; Alendronate sodium [USAN]; Alendronate sodium hydrate; Alendros; Aminohydroxybutylidene biphosphonate monosodium salt trihydrate; Dronal; Elandor; Fosalan; G-704,650; LS-106424; Monosodium (4-amino-1-hydroxybutylidene)bisphosphonate trihydrate; P

Adronat; Alendros; Arendal; Fosamax

AHBuBP

AHButBP

AKOS001015793

Alendronate

Alendronate (Fosamax)

Alendronate (sodium hydrate)

Alendronate monosodium trihydrate

Alendronate Sodium

Alendronate sodium trihydrate

alendronate(1-)

Alendronate, Sodium Salt

Alendronate; Alendronate Sodium; Alendronate sodium hydrate; Alendronic acid; Fosamax

Alendronate;Alendronate Sodium;Alendronate sodium hydrate;Alendronic acid;Fosamax

ALENDRONATESODIUM

Alendronic Acid

Alendronic Acid (BAN

Alendronic acid (INN)

Alendronic acid sodium salt

Alendronic acid [INN:BAN]

Alendronic acid, Sodium aldendronate

Alendros

Almerol

Arendal

Avalent

BIDD:GT0180

Binosto

bisphosphonate, 65

Bonalon

C07752

CHEBI:2567

CHEMBL870

CID2088

D07119

DAP000182

DB00630

EX-101

FDA)

Fosamac

Fosamax

Fosamax Plus D

G-704650

G-704650; MK-217

GTH-42

GTH-42J

GTH-42V

GTH-42W

HSCI1_000337

hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate

INN); Alendronate Sodium (FDA

INN); Alendronate Sodium (USP

L-670452

LS-106421

MER-103

MFCD00868112

MFCD01748233

MFCD01861681

MK 217

MK-0217

MK-217

MolPort-000-421-410

Monosodium (4-amino-1-hydroxybutylidene)bisphosphonate trihydrate

N/A

NCGC00096054-01

NCGC00096054-03

NCGC00096054-04

Onclast

Oprea1_422906

phosphonate, (4-amino-1-hydroxy-1-phosphonobutyl)-, sodium salt

Phosphonic acid, (4-amino-1-hydroxybutylidene)bis

Phosphonic acid, (4-amino-1-hydroxybutylidene)bis-

phosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt

QA-1754

QA-7982

Sodium alendronate

sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate

SPECTRUM1505166

ST50036159

Steovess

Teiroc

UNII-X1J18R4W8P

USAN

USP)

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -3.46 -6.41 -192.84 5 8 -2 171 247.08 5
Mid Mid (pH 6-8) -3.46 -7.52 -96.13 6 8 -1 169 248.088 5

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 1.69e+01 g/l DrugBank-approved
Purity 95% Fluorochem
Purity 98% Matrix Scientific
Purity >98% Matrix Scientific
Indications bisphosphonate KeyOrganics Bioactives
Therapy bone resorption inhibitor, farnesyldiphosphate synthetase inhibitor, antimetastatic SMDC Pharmakon
Patent Database Links EP1127573; EP1803727 ChEBI
Warnings IRRITANT Matrix Scientific
Indications osteoporosis KeyOrganics Bioactives
Target Others Selleck Chemicals

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
FPPS-1-E Farnesyl Diphosphate Synthase (cluster #1 Of 1), Eukaryotic Eukaryotes 950 0.60 Binding ≤ 10μM
Q0GKD7-1-E Farnesyl Pyrophosphate Synthase (cluster #1 Of 1), Eukaryotic Eukaryotes 95 0.70 Binding ≤ 10μM
Z50594-3-O Mus Musculus (cluster #3 Of 9), Other Other 50 0.73 Functional ≤ 10μM
Z50597-2-O Rattus Norvegicus (cluster #2 Of 12), Other Other 100 0.70 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
FPPS_HUMAN P14324 Farnesyl Diphosphate Synthase, Human 260 0.66 Binding ≤ 1μM
Q0GKD7_LEIDO Q0GKD7 Farnesyl Pyrophosphate Synthase, Leido 95 0.70 Binding ≤ 1μM
FPPS_HUMAN P14324 Farnesyl Diphosphate Synthase, Human 2249 0.56 Binding ≤ 10μM
Q0GKD7_LEIDO Q0GKD7 Farnesyl Pyrophosphate Synthase, Leido 95 0.70 Binding ≤ 10μM
Z50594 Z50594 Mus Musculus 290 0.65 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 100 0.70 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Activation of gene expression by SREBF (SREBP)
Cholesterol biosynthesis

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.